290 related articles for article (PubMed ID: 23281216)
1. Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial.
Min K; Song J; Kang JY; Ko J; Ryu JS; Kang MS; Jang SJ; Kim SH; Oh D; Kim MK; Kim SS; Kim M
Stem Cells; 2013 Mar; 31(3):581-91. PubMed ID: 23281216
[TBL] [Abstract][Full Text] [Related]
2. Maintenance of the synergistic effects of cord blood cells and erythropoietin combination therapy after additional cord blood infusion in children with cerebral palsy: 1-year open-label extension study of randomized placebo-controlled trial.
Suh MR; Min K; Cho KH; Kim J; Lim I; Park M; Noh EM; Kim MY
Stem Cell Res Ther; 2023 Dec; 14(1):362. PubMed ID: 38087394
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of cord blood cell therapy with erythropoietin for children with CP: a 2 × 2 factorial randomized placebo-controlled trial.
Min K; Suh MR; Cho KH; Park W; Kang MS; Jang SJ; Kim SH; Rhie S; Choi JI; Kim HJ; Cha KY; Kim M
Stem Cell Res Ther; 2020 Nov; 11(1):509. PubMed ID: 33246489
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Immune Responses in the Efficacy of Cord Blood Cell Therapy for Cerebral Palsy.
Kang M; Min K; Jang J; Kim SC; Kang MS; Jang SJ; Lee JY; Kim SH; Kim MK; An SA; Kim M
Stem Cells Dev; 2015 Oct; 24(19):2259-68. PubMed ID: 25977995
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of erythropoietin on neurodevelopment in infants with cerebral palsy: a pilot study.
Lee HS; Song J; Min K; Choi YS; Kim SM; Cho SR; Kim M
Brain Dev; 2014 Oct; 36(9):764-9. PubMed ID: 24314853
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial.
Zarrabi M; Akbari MG; Amanat M; Majmaa A; Moaiedi AR; Montazerlotfelahi H; Nouri M; Hamidieh AA; Badv RS; Karimi H; Rabbani A; Mohebbi A; Rahimi-Dehgolan S; Rahimi R; Dehghan E; Vosough M; Abroun S; Shamsabadi FM; Tavasoli AR; Alizadeh H; Pak N; Zamani GR; Mohammadi M; Javadzadeh M; Ghofrani M; Hassanpour SH; Heidari M; Taghdiri MM; Mohseni MJ; Noparast Z; Masoomi S; Goudarzi M; Mohamadpour M; Shodjaee R; Samimi S; Mohammad M; Gholami M; Vafaei N; Koochakzadeh L; Valizadeh A; Malamiri RA; Ashrafi MR
BMC Neurol; 2022 Mar; 22(1):123. PubMed ID: 35351020
[TBL] [Abstract][Full Text] [Related]
7. Allogenic umbilical cord blood therapy combined with erythropoietin for patients with severe traumatic brain injury: three case reports.
Min K; Song J; Lee JH; Kang MS; Jang SJ; Kim SH; Kim M
Restor Neurol Neurosci; 2013; 31(4):397-410. PubMed ID: 23515110
[TBL] [Abstract][Full Text] [Related]
8. Effect of Autologous Cord Blood Infusion on Motor Function and Brain Connectivity in Young Children with Cerebral Palsy: A Randomized, Placebo-Controlled Trial.
Sun JM; Song AW; Case LE; Mikati MA; Gustafson KE; Simmons R; Goldstein R; Petry J; McLaughlin C; Waters-Pick B; Chen LW; Wease S; Blackwell B; Worley G; Troy J; Kurtzberg J
Stem Cells Transl Med; 2017 Dec; 6(12):2071-2078. PubMed ID: 29080265
[TBL] [Abstract][Full Text] [Related]
9. Neuroregenerative potential of intravenous G-CSF and autologous peripheral blood stem cells in children with cerebral palsy: a randomized, double-blind, cross-over study.
Rah WJ; Lee YH; Moon JH; Jun HJ; Kang HR; Koh H; Eom HJ; Lee JY; Lee YJ; Kim JY; Choi YY; Park K; Kim MJ; Kim SH
J Transl Med; 2017 Jan; 15(1):16. PubMed ID: 28109298
[TBL] [Abstract][Full Text] [Related]
10. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
[TBL] [Abstract][Full Text] [Related]
11. DTI Tract-Based Quantitative Susceptibility Mapping: An Initial Feasibility Study to Investigate the Potential Role of Myelination in Brain Connectivity Change in Cerebral Palsy Patients During Autologous Cord Blood Cell Therapy Using a Rotationally-Invariant Quantitative Measure.
Zhang L; Ellor S; Sun JM; Liu C; Kurtzburg J; Song AW
J Magn Reson Imaging; 2021 Jan; 53(1):251-258. PubMed ID: 32677156
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.
Gu J; Huang L; Zhang C; Wang Y; Zhang R; Tu Z; Wang H; Zhou X; Xiao Z; Liu Z; Hu X; Ke Z; Wang D; Liu L
Stem Cell Res Ther; 2020 Feb; 11(1):43. PubMed ID: 32014055
[TBL] [Abstract][Full Text] [Related]
13. Human allogeneic AB0/Rh-identical umbilical cord blood cells in the treatment of juvenile patients with cerebral palsy.
Romanov YA; Tarakanov OP; Radaev SM; Dugina TN; Ryaskina SS; Darevskaya AN; Morozova YV; Khachatryan WA; Lebedev KE; Zotova NS; Burkova AS; Sukhikh GT; Smirnov VN
Cytotherapy; 2015 Jul; 17(7):969-78. PubMed ID: 25791070
[TBL] [Abstract][Full Text] [Related]
14. Motor function and safety after allogeneic cord blood and cord tissue-derived mesenchymal stromal cells in cerebral palsy: An open-label, randomized trial.
Sun JM; Case LE; McLaughlin C; Burgess A; Skergan N; Crane S; Jasien JM; Mikati MA; Troy J; Kurtzberg J
Dev Med Child Neurol; 2022 Dec; 64(12):1477-1486. PubMed ID: 35811372
[TBL] [Abstract][Full Text] [Related]
15. Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: a randomized double-blind sham-controlled clinical trial.
Amanat M; Majmaa A; Zarrabi M; Nouri M; Akbari MG; Moaiedi AR; Ghaemi O; Zamani F; Najafi S; Badv RS; Vosough M; Hamidieh AA; Salehi M; Montazerlotfelahi H; Tavasoli AR; Heidari M; Mohebi H; Fatemi A; Garakani A; Ashrafi MR
Stem Cell Res Ther; 2021 Aug; 12(1):439. PubMed ID: 34362453
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Allogeneic Umbilical Cord Blood Therapy for Global Development Delay and Intellectual Disability.
Cha B; Kwak H; Bang JI; Jang SJ; Suh MR; Choi JI; Kim M
Stem Cells Dev; 2023 Apr; 32(7-8):170-179. PubMed ID: 36734415
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease.
Jang W; Park J; Shin KJ; Kim JS; Kim JS; Youn J; Cho JW; Oh E; Ahn JY; Oh KW; Kim HT
J Neurol Sci; 2014 Feb; 337(1-2):47-54. PubMed ID: 24289887
[TBL] [Abstract][Full Text] [Related]
18. Clinical Trial of Erythropoietin in Young Children With Cerebral Palsy.
Cho KH; Min K; Lee SH; Lee S; An SA; Kim M
J Child Neurol; 2016 Sep; 31(10):1227-34. PubMed ID: 27233796
[TBL] [Abstract][Full Text] [Related]
19. A Randomized, Placebo-Controlled Trial of Human Umbilical Cord Blood Mesenchymal Stem Cell Infusion for Children With Cerebral Palsy.
Huang L; Zhang C; Gu J; Wu W; Shen Z; Zhou X; Lu H
Cell Transplant; 2018 Feb; 27(2):325-334. PubMed ID: 29637820
[TBL] [Abstract][Full Text] [Related]
20. Safety and feasibility of autologous umbilical cord blood transfusion in 2 toddlers with cerebral palsy and the role of low dose granulocyte-colony stimulating factor injections.
Papadopoulos KI; Low SS; Aw TC; Chantarojanasiri T
Restor Neurol Neurosci; 2011; 29(1):17-22. PubMed ID: 21335665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
